ArticleCureus2025
Giant Cell Tumor in the Thoracolumbar Junction: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A giant cell tumor (GCT) of the spine is an uncommon benign bone neoplasm that can behave aggressively and cause neurological compromise. Its rarity and location within load-bearing, neuro-critical anatomy make diagnosis and management particularly complex. A 34-year-old woman presented with progressive thoracolumbar pain, kyphotic deformity, and incomplete spinal cord injury leading to transient paraplegia. Radiographs showed 90% collapse of the L1 vertebral body with about 45° regional kyphosis. Magnetic resonance imaging revealed an expansile lytic lesion at L1 with paravertebral extension and severe canal compromise. Definitive management was achieved through a posterior-only approach using a Schwab type five osteotomy, mesh-cage reconstruction with autograft, and T12-L4 instrumentation. Postoperatively, the patient showed rapid sensory recovery below T11 and preserved motor function, regaining ambulation within 24 hours. Follow-up imaging confirmed correction of deformity and construct stability. Histopathology demonstrated multinucleated giant cells in a mononuclear stromal background, confirming GCT. Locoregional recurrence was identified eight months postoperatively. This case highlights the value of prompt recognition and meticulous surgical planning in spinal GCT. Early intervention with complete resection and stabilization can restore alignment, prevent permanent neurological deficits, and achieve durable local control. Multidisciplinary management is crucial for optimizing outcomes in these rare but challenging lesions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.